EASD 24 - We are joined by Professor John McMurray (University of Glasgow, UK) to discuss the key findings from a diabetes subgroup analysis of the FINEARTS-HF study.

Interview Questions:
1. What is the reasoning behind this analysis?
2. What was the study design and patient cohort?
3. What are the key findings?
4. In your opinion, what can explain this risk reduction?
5.  What are the take-home messages for practice?
6. What are the next steps?

Recorded remotely from Glasgow, 2024.